After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Verona Pharma Plc ADR is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Verona Pharma Plc ADR is $3.44B. A total of 0.73 million shares were traded on the day, compared to an average of 1.01M shares.
In the most recent transaction, ZACCARDELLI DAVID sold 640,264 shares of VRNA for 5.01 per share on Dec 05 ’24. After the transaction, the President and CEO now owns 14,367,552 company shares. In a previous transaction on Dec 06 ’24, ZACCARDELLI DAVID sold 162,800 shares at 5.01 per share. VRNA shares that President and CEO owns now total 14,204,752.
Among the insiders who sold shares, ZACCARDELLI DAVID disposed of 67,608 shares on Dec 04 ’24 at a per-share price of $5.00. This resulted in the President and CEO holding 15,007,816 shares of VRNA after the transaction. In another insider transaction, Hahn Mark W sold 640,048 shares at $5.01 per share on Dec 05 ’24. Company shares held by the Chief Financial Officer now total 13,477,464.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, VRNA has a high of $43.73 and a low of $11.39.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $1.59, while its Total Shareholder’s Equity was $148.00M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRNA is Buy with a score of 5.00.
